1. Home
  2. MRLN vs NYXH Comparison

MRLN vs NYXH Comparison

Compare MRLN & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merlin Inc. Common Stock

MRLN

Merlin Inc. Common Stock

HOLD

Current Price

$0.87

Market Cap

172.8M

Sector

Technology

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

BUY

Current Price

$0.85

Market Cap

137.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
MRLN
NYXH
Founded
2018
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.8M
137.5M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
MRLN
NYXH
Price
$0.87
$0.85
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
★ $7.92
$4.20
AVG Volume (30 Days)
★ 2.9M
217.2K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$9.23
$275.91
Revenue Next Year
$153.29
$93.27
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$0.80
52 Week High
$17.00
$5.92

Technical Indicators

Market Signals
Indicator
MRLN
NYXH
Relative Strength Index (RSI) 21.73 23.47
Support Level N/A N/A
Resistance Level $3.45 $1.69
Average True Range (ATR) 0.12 0.05
MACD 0.02 -0.05
Stochastic Oscillator 7.48 5.85

Price Performance

Historical Comparison
MRLN
NYXH

About MRLN Merlin Inc. Common Stock

Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: